BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26593979)

  • 1. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
    Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
    Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
    Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
    Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
    Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
    Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
    Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
    J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
    Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
    Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
    FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-Mediated Interference of PB2-eIF4G1 Interaction Inhibits Influenza A Viruses' Replication in Vitro and in Vivo.
    Yuan S; Chu H; Ye J; Hu M; Singh K; Chow BK; Zhou J; Zheng BJ
    ACS Infect Dis; 2016 Jul; 2(7):471-7. PubMed ID: 27626099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
    Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
    Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza A virus by mixed siRNAs, targeting the PA, NP, and NS genes, delivered by hybrid microcarriers.
    Brodskaia AV; Timin AS; Gorshkov AN; Muslimov AR; Bondarenko AB; Tarakanchikova YV; Zabrodskaya YA; Baranovskaya IL; Il'inskaja EV; Sakhenberg EI; Sukhorukov GB; Vasin AV
    Antiviral Res; 2018 Oct; 158():147-160. PubMed ID: 30092251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.
    Wanitchang A; Jengarn J; Jongkaewwattana A
    Virus Res; 2011 Jan; 155(1):325-33. PubMed ID: 21056603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
    Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
    Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
    Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
    J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
    Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
    Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
    Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
    Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.
    Yamayoshi S; Watanabe M; Goto H; Kawaoka Y
    J Virol; 2016 Jan; 90(1):444-56. PubMed ID: 26491155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.